Literature DB >> 11824659

Saccadic eye movements are impaired in Duchenne muscular dystrophy.

F Lui1, S Fonda, L Merlini, R Corazza.   

Abstract

Extraocular muscles are generally considered to be spared in Duchenne Muscular Dystrophy (DMD). However, this assumption is based mainly on clinical observations, as systematic eye movement recordings have been performed in a very limited number of cases. Our goal was to analyze several saccade parameters in a higher number of cases, in order to reveal a possible ocular-motor impairment in DMD. Data were collected from a population of 9 subjects with DMD and 9 healthy male subjects of comparable age as controls. We used the electrooculographic (EOG) technique coupled with advanced digital signal processing; saccade duration, amplitude, mean velocity, peak velocity and K factor (ratio mean/peak velocity) were measured. The DMD group showed saccades with significantly longer duration and lower velocity, with respect to controls; these differences were accounted for mainly by the largest movements, whereas there were no significant differences at the smallest eccentricity tested (3 deg). Neither amplitude nor K factor were significantly different from controls for any of the eccentricities tested. To our knowledge. this is the first study to suggest significant impairment of eye movements in Duchenne muscular dystrophy.

Entities:  

Mesh:

Year:  2001        PMID: 11824659     DOI: 10.1023/a:1013041713837

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  15 in total

1.  Some characteristics of saccadic eye movements in children of primary school age.

Authors:  A P Accardo; S Pensiero; S Da Pozzo; P Perissutti
Journal:  Doc Ophthalmol       Date:  1992       Impact factor: 2.379

2.  Extraocular muscles are spared in advanced Duchenne dystrophy.

Authors:  H J Kaminski; M al-Hakim; R J Leigh; M B Katirji; R L Ruff
Journal:  Ann Neurol       Date:  1992-10       Impact factor: 10.422

3.  Fast muscle fibers are preferentially affected in Duchenne muscular dystrophy.

Authors:  C Webster; L Silberstein; A P Hays; H M Blau
Journal:  Cell       Date:  1988-02-26       Impact factor: 41.582

4.  Extraocular muscle involvement in Becker muscular dystrophy.

Authors:  S N Scelsa; D M Simpson; B D Reichler; M Dai
Journal:  Neurology       Date:  1996-02       Impact factor: 9.910

Review 5.  Muscles of a different 'color': the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease.

Authors:  J D Porter; R S Baker
Journal:  Neurology       Date:  1996-01       Impact factor: 9.910

6.  Localization of dystrophin to postsynaptic regions of central nervous system cortical neurons.

Authors:  H G Lidov; T J Byers; S C Watkins; L M Kunkel
Journal:  Nature       Date:  1990 Dec 20-27       Impact factor: 49.962

Review 7.  Eye muscle sparing by the muscular dystrophies: lessons to be learned?

Authors:  F H Andrade; J D Porter; H J Kaminski
Journal:  Microsc Res Tech       Date:  2000 Feb 1-15       Impact factor: 2.769

8.  Small-caliber skeletal muscle fibers do not suffer necrosis in mdx mouse dystrophy.

Authors:  G Karpati; S Carpenter; S Prescott
Journal:  Muscle Nerve       Date:  1988-08       Impact factor: 3.217

9.  Deletion status and intellectual impairment in Duchenne muscular dystrophy.

Authors:  K M Bushby; R Appleton; L V Anderson; J L Welch; P Kelly; D Gardner-Medwin
Journal:  Dev Med Child Neurol       Date:  1995-03       Impact factor: 5.449

10.  Disorders of eye movement in myotonic dystrophy.

Authors:  J P Ter Bruggen; L A Bastiaensen; C C Tyssen; G Gielen
Journal:  Brain       Date:  1990-04       Impact factor: 13.501

View more
  1 in total

1.  Association of the DTNBP1 locus with schizophrenia in a U.S. population.

Authors:  Birgit Funke; Christine T Finn; Alex M Plocik; Stephen Lake; Pamela DeRosse; John M Kane; Raju Kucherlapati; Anil K Malhotra
Journal:  Am J Hum Genet       Date:  2004-09-10       Impact factor: 11.025

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.